(Q36036299)

11 August 2017

JAK2V617F somatic mutation in the general population: myeloproliferative neoplasm development and progression rate (English)

1 reference

myeloproliferative neoplasm

11 August 2017

1 reference

inferred from title

author

Børge G. Nordestgaard

series ordinal

3

object named as

Børge G Nordestgaard

0 references

Klaus Kofoed

object named as

Klaus F Kofoed

series ordinal

4

0 references

Stig Egil Bojesen

series ordinal

2

object named as

Stig E Bojesen

1 reference

11 August 2017

5

Henrik S Birgens

1 reference

11 August 2017

Camilla Nielsen

1

1 reference

11 August 2017

6 June 2014

1 reference

11 August 2017

1 reference

11 August 2017

99

1 reference

11 August 2017

9

1 reference

11 August 2017

1448-1455

1 reference

JAK2 Allele Burden in the Myeloproliferative Neoplasms: Effects on Phenotype, Prognosis and Change with Treatment.

11 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4562533

Evaluation of the association between the JAK2 46/1 haplotype and chronic myeloproliferative neoplasms in a Brazilian population.

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4562533

Environmental, lifestyle, and familial/ethnic factors associated with myeloproliferative neoplasms

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4562533

The JAK2 V617F somatic mutation, mortality and cancer risk in the general population

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4562533

A germline JAK2 SNP is associated with predisposition to the development of JAK2(V617F)-positive myeloproliferative neoplasms

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4562533

JAK2 haplotype is a major risk factor for the development of myeloproliferative neoplasms

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4562533

Genetically elevated C-reactive protein and ischemic vascular disease

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4562533

Classification and diagnosis of myeloproliferative neoplasms: the 2008 World Health Organization criteria and point-of-care diagnostic algorithms

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4562533

JAK2(V617F): Prevalence in a large Chinese hospital population

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4562533

Definition of subtypes of essential thrombocythaemia and relation to polycythaemia vera based on JAK2 V617F mutation status: a prospective study.

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4562533

Diagnostic value of JAK2 V617F somatic mutation for myeloproliferative cancer in 49 488 individuals from the general population

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4562533

A common JAK2 haplotype confers susceptibility to myeloproliferative neoplasms.

23 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4562533

The allele burden of JAK2 mutations remains stable over several years in patients with myeloproliferative disorders.

23 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4562533

Association of loss-of-function mutations in the ABCA1 gene with high-density lipoprotein cholesterol levels and risk of ischemic heart disease

23 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4562533

The JAK2 V617F allele burden in essential thrombocythemia, polycythemia vera and primary myelofibrosis--impact on disease phenotype

23 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4562533

The Danish Civil Registration System. A cohort of eight million persons.

23 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4562533

Nonfasting Triglycerides and Risk of Myocardial Infarction, Ischemic Heart Disease, and Death in Men and Women

23 September 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/24907356

12 December 2020

inferred from PubMed ID database lookup

The JAK2V617F mutation is detectable at very low level in peripheral blood of healthy donors

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/24907356

12 December 2020

inferred from PubMed ID database lookup

Incidence of the JAK2 V617F mutation among patients with splanchnic or cerebral venous thrombosis and without overt chronic myeloproliferative disorders

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/24907356

12 December 2020

inferred from PubMed ID database lookup

Identifiers

DOI

10.3324/HAEMATOL.2014.107631

1 reference

11 August 2017

1 reference

PMC publication ID

4562533

11 August 2017

PubMed publication ID

24907356

1 reference

PMC publication ID

4562533